Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Neurobiology

ISSN Imprimir: 0892-0915
ISSN En Línea: 2375-0014

Archives: Volume 10, 1996 to Volume 20, 2008

Critical Reviews™ in Neurobiology

DOI: 10.1615/CritRevNeurobiol.v14.i1.30
20 pages

Herpes Simplex Virus-Mediated Gene Transfer As a Tool for Neuropsychiatric Research

William A. Carlezon, Jr.
Department of Psychiatry, Harvard Medical School and McLean Hospital, Belmont, MA 02478
Eric J. Nestler
Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas TX 75390
Rachael L. Neve
Department of Psychiatry, Harvard Medical School and McLean Hospital, Belmont, MA 02478


There is an enormous initiative to establish causal relationships between brain biology (including patterns of gene expression) and behavior. Unfortunately, genetic intervention is not accomplished easily in the brain. One strategy is to engineer and deliver to the brain specialized viral vectors that carry a gene (or genes) of interest, thereby exploiting the natural ability of viruses to insert genetic information into cells. When delivered to the brain, these vectors cause infected cells to increase expression of the genes of interest. Viral vectors are particularly useful when the goal is to manipulate expression of a single gene in a specific brain region, at a specific time, and in animals that developed normally. There are several types of virus that can be adapted for use as viral vectors, including those based on herpes simplex virus (HSV-1), adenovirus (AV), adeno-associated virus (AAV), and lentivirus. Although each vector has its own unique advantages and disadvantages, this rapidly evolving technology has the potential to revolutionize neuropsychiatric research by offering the opportunity to establish, with anatomical and temporal specificity, causal relations between altered expression of individual gene products and alterations in complex behavior.